Clotrimazole/Betamethasone Dip
Brand name: Clotrimazole-Betamethasone
Rank #486 of 500 drugs by total cost
$14.4M
Total Cost
503,015
Total Claims
$14.4M
Total Cost
17,644
Prescribers
$29
Cost per Claim
210,776
Beneficiaries
530,089
30-Day Fills
$817
Avg Cost/Provider
29
Avg Claims/Provider
About Clotrimazole/Betamethasone Dip
Clotrimazole/Betamethasone Dip (sold as Clotrimazole-Betamethasone) was prescribed 503,015 times by 17,644 Medicare Part D providers in 2023, costing the program $14.4M. At $29 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 483 | Pazopanib Hcl (Votrient) | $14.5M | 1,156 |
| 484 | Exemestane (Exemestane) | $14.5M | 66,285 |
| 485 | Dihydroergotamine Mesylate (Dihydroergotamine Mesylate) | $14.4M | 6,855 |
| 486 | Clotrimazole/Betamethasone Dip (Clotrimazole-Betamethasone) | $14.4M | 503,015 |
| 487 | Verapamil Hcl (Verapamil Er) | $14.4M | 329,950 |
| 488 | Eteplirsen (Exondys-51) | $14.4M | 192 |
| 489 | Colesevelam Hcl (Colesevelam Hcl) | $14.3M | 50,268 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology